Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Tumor-destroying sound waves receive FDA approval for liver

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Oct 17, 2023 7:53pm

283 Views

Post# 35688146

RE:RE:RE:Tumor-destroying sound waves receive FDA approval for liver

	N417.PYMT	Electronic Fee Payment

I may be ahead of myself on that last post. Understanding of the language of the documents can be a struggle at times :-))

I think in going back to an approved document (as an example) that item "Issue Fee Payment" is actually the USPTO saying to the Company that they have been issued a request for fee payment ($480). After the Company pays the money (by card or whatever) the item for that will be:

I could be wrong but it seems the ball may be in the Company's court right now to pay the fee, and then the patent issue can take place.

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?